Condition · ICD-10 F90.0

ADHD

Attention-Deficit/Hyperactivity Disorder

A neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity that interferes with functioning.

ADHD is one of the most common neurodevelopmental disorders, affecting children and persisting into adulthood in the majority of cases. It involves dysregulation of dopamine and norepinephrine pathways in the prefrontal cortex. Stimulant medications (amphetamines and methylphenidate) are first-line pharmacotherapy with robust evidence of efficacy.

At a glance
Medications tracked
8
First-line options
Amphetamine, Lisdexamfetamine, Methylphenidate, Methylphenidate, Amphetamine Extended-Release
Related conditions
Anxiety DisorderDepressionLearning DisabilitiesBipolar Disorder

First-line Related Treatments

Commonly associated primary options — verify with your clinician

Primary options
Amphetamine
Amphetamine
Rx
Tablet
Strength 10 mg
NDC 24478-108-01
Lisdexamfetamine
Lisdexamfetamine
Rx
Capsule
Strength 10 mg
NDC 0378-6854-77
Methylphenidate
Methylphenidate
Rx
Tablet
Strength 10 mg
NDC 0115-1801-01
Methylphenidate
Methylphenidate
Rx
Capsule
Strength 10 mg
NDC 0781-2361-01
Amphetamine Extended-Release
Amphetamine Extended-Release
Rx
Tablet
Strength 12.5 mg
NDC 62542-020-30

Short-term / As-needed

Related options for acute or bridging use

Acute or bridging use
Atomoxetine
Atomoxetine
Rx
Capsule
Strength 10 mg
NDC 0093-3542-56

Situational

Related options for specific presentations

Specific presentations
Guanfacine
Guanfacine
Rx
Tablet
Strength 1 mg
NDC 0228-2850-11
Guanfacine ER
Guanfacine ER
Rx
Tablet
Strength 1 mg
NDC 72189-469-30

Top treatments tried for ADHD

Community-driven data · early preview

Amphetamine
1,800 people tried
4.3
Lisdexamfetamine
1,520 people tried
4.1
Methylphenidate
1,240 people tried
4.0
Methylphenidate
960 people tried
3.8
Help build the dataset — log treatments you've tried, rate what helped, and report side effects.